US Stocks

AN2 Therapeutics, Inc.

AN2 Therapeutics is a biopharmaceutical company dedicated to treating serious and rare infectious diseases. They are working on epetraborole, an oral treatment for chronic non-tuberculous mycobacterial lung disease. Founded in 2017, the company's headquarters are in Menlo Park, California.